Skip to main content
SpringerLink
Log in

Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Because of the possible interference of antiphospholipid antibodies (APL) with the phospholipid component of thromboplastin reagents, concerns have been raised about the validity of international normalized ratio (INR) testing to monitor anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome (APS). To investigate the reliability of the INR, we determined the INR using various prothrombin time (PT) assays and compared the results with those of a chromogenic factor X (CFX) assay. The study cohort consisted of 40 APS patients and 100 APL-negative patients who were on anticoagulant therapy for reasons other than APS. The agreement (i.e. the percentage of patients with a difference ≤0.5 INR units) between the PT-derived INR and CFX-derived INR equivalents was only moderate in both patient groups. The best agreement with CFX-derived INR equivalents was observed for the Thromborel S reagent in APS patients (69.1 %) and for Neoplastin Plus in APL-negative patients (72.0 %). Regarding the results for the point-of-care system CoaguChek XS, an agreement between the INR and the CFX-derived INR equivalent was less frequently observed in the APS patients (55.6 vs. 67.8 %; p = 0.050). When considering all 3058 pairs of INR tests within the international sensitivity index (ISI)-calibrated range of 1.5 to 4.5 s, we did not observe a higher variability of INR values in either the APS patient group or the subgroup of APS patients positive for lupus coagulants compared with the APL-negative controls. In conclusion, monitoring vitamin K antagonists (VKA) therapy with laboratory INR measurements seems to be suitable for the majority of APS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Du VX, Kelchtermans H, de Groot PG, de Laat B (2013) From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. Thromb Res 132:319–326

    Article  CAS  PubMed  Google Scholar 

  2. Favaloro EJ, Wong RC (2011) Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 49:447–461

    CAS  PubMed  Google Scholar 

  3. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 8:237–242

    Article  CAS  PubMed  Google Scholar 

  4. Favaloro EJ, McVicker W, Hamdam S, Hocker N (2010) Improving the harmonisation of the international normalized ratio (INR): time to think outside the box? Clin Chem Lab Med 48:1079–1090

    CAS  PubMed  Google Scholar 

  5. WHO Expert Committee on Biological Standardization (1999) Guidelines for thromboplastins and plasma used to monitor oral anticoagulant therapy. World Health Organization Technical Report Series; no. 889. Geneva, WHO

  6. Crowther M, Crowther MA (2010) Intensity of warfarin coagulation in the antiphospholipid syndrome. Curr Rheumatol Rep 12:64–69

    Article  CAS  PubMed  Google Scholar 

  7. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, Committee B, British Committee for Standards in Haematology (2012) Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 157:47–58

    Article  CAS  PubMed  Google Scholar 

  8. Poller L (2004) International normalized ratios (INR): the first 20 years. J Thromb Haemost 2:849–860

    Article  CAS  PubMed  Google Scholar 

  9. Smith SA, Comp PC, Mirrissey JH (2006) Phospholipid composition controls thromboplastin sensitivity to individual clotting factors. J Thromb Haemost 4:820–827

    Article  CAS  PubMed  Google Scholar 

  10. Robert A, Le Querrec A, Delahousse B, Caron C, Houbouyan L, Boutière B et al (1998) Control of oral anticoagulation in patients with the antiphospholipid syndrome – influence of the lupus anticoagulant on international normalized ratio. Thromb Haemost 80:99–103

    CAS  PubMed  Google Scholar 

  11. Rosborough TK, Shepherd MF (2004) Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Pharmacotherapy 24:838–842

    Article  CAS  PubMed  Google Scholar 

  12. Lawrie AS, Purdy G, Mackie IJ, Machin SJ (1997) Monitoring oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 98:887–892

    Article  CAS  PubMed  Google Scholar 

  13. Bijsterveld NR, Middeldorp S, Berends F, Büller HR (2000) Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulants: effect on different tests for INR determination. J Thromb Thrombolysis 9:263–269

    Article  CAS  PubMed  Google Scholar 

  14. Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol 115:672–678

    Article  CAS  PubMed  Google Scholar 

  15. Crowl A, Schullo-Feulner A, Moon JY (2014) Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant. Ann Pharmacother 48:1479–1483

    Article  CAS  PubMed  Google Scholar 

  16. Plesch W, Wolf T, Breitenbeck N, Dikkeschei LD, Cervero A, Perez PL et al (2008) Results of the performance verification of the CoaguChek XS system. Thromb Res 123:381–389

    Article  CAS  PubMed  Google Scholar 

  17. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M et al (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 7:1737–1740

    Article  CAS  PubMed  Google Scholar 

  18. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185–1190

    CAS  PubMed  Google Scholar 

  19. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  20. McGlasson DL, Romick BG, Rubal BJ (2008) Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy. Blood Coagul Fibrinolysis 19:513–517

    Article  CAS  PubMed  Google Scholar 

  21. Baumann Kreuziger LM, Datta YH, Johnson AD, Zantek ND, Shanley R, Reding MT (2014) Monitoring anticoagulation in patients with an unreliable prothrombin time/international normalized ratio: factor II versus chromogenic factor X testing. Blood Coagul Fibrinolysis 25:232–236

    Article  CAS  PubMed  Google Scholar 

  22. Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, D’Angelo V et al (1999) Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in antiphospholipid-antibody syndrome. Haematologica 84:1065–1074

    CAS  PubMed  Google Scholar 

  23. Rosborough TK, Jacobsen JM, Shepherd MF (2009) Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration. Blood Coagul Fibrinolysis 20:433–435

    Article  CAS  PubMed  Google Scholar 

  24. Remijn JA, Lucas S, Wildeboer B, van Suijlen JD, Adriaansen HJ (2008) Strongly increased international normalized ratio with recombinant Neoplastin R compared with tissue extract Neoplastin Plus in patients initiating oral anticoagulation therapy: implications for anticoagulation dosage. Clin Chem 54:1929–1931

    Article  CAS  PubMed  Google Scholar 

  25. Remijn JA, Wildeboer B, van Suijlen JDE, Adiaansen HJ (2011) Recombinant thromboplastins vs. tissue-extract thromboplastins in patients on unstable oral anticoagulant therapy. Clin Chem 57:916–917

    Article  CAS  PubMed  Google Scholar 

  26. Solvik UO, Roraas TH, Petersen PH, Stavelin AV, Monsen G, Sandberg S (2012) Effect of coagulation factors on discrepancies in international normalized ratio results between instruments. Clin Chem Lab Med 50:1611–1620

    Article  PubMed  Google Scholar 

  27. Carrasco C, Campbell B, Shiach C (2004) Effects of the lupus anticoagulant on the control of oral anticoagulant treatment. Br J Haematol 124:555–563

    Article  Google Scholar 

  28. Shermock KM, Streiff MB, Pinto BL, Kraus P, Pronovost PJ (2011) Novel analysis of clinically relevant diagnostic errors in point-of-care devices. J Thromb Haemost 9:1769–1775

    Article  CAS  PubMed  Google Scholar 

  29. Barcellona D, Fenu L, Vannini ML, Piras M, Marongiu F (2012) Antiphospholipid syndrome patients: the performance of CoaguChek XS in monitoring of vitamin K antagonists. Thromb Res 129:e168–e170

    Article  CAS  PubMed  Google Scholar 

  30. Christensen TD, Larsen TB, Jensen C, Maegaard M, Sorensen B (2009) International normalized ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy. Thromb Haemost 101:563–569

    CAS  PubMed  Google Scholar 

  31. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P (2006) Self-monitoring of oral anticoagulation: a systemic review and meta-analysis. Lancet 367:404–411

    Article  CAS  PubMed  Google Scholar 

  32. Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM (2007) Self-management of oral anticoagulant therapy: a systemic review and meta-analysis. Int J Cardiol 118:54–61

    Article  PubMed  Google Scholar 

  33. Schulman S, Kearon C, on behalf of the subcommittee on control of anticoagulation of the Scientific and Standardization committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Scientific and Standardization Committee Communication. J Thromb Haemost 3:692–694

    Article  CAS  PubMed  Google Scholar 

  34. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Vascular Medicine, Department of Internal Medicine, Goethe University Hospital, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany

    Mecki Isert, Gundolf Schüttfort, Yvonne Weil, Vanessa Tirneci, Alexander Kasper, Adele Weber, Edelgard Lindhoff-Last & Birgit Linnemann

  2. Frankfurt Haemophilia Center, Institute of Transfusion Medicine, Goethe University Hospital, Frankfurt/Main, Germany

    Wolfgang Miesbach

  3. Institute of Biostatistics and Math, Modelling, Faculty of Medicine, Goethe University Hospital, Frankfurt/Main, Germany

    Eva Herrmann

Authors
  1. Mecki Isert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Miesbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gundolf Schüttfort
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yvonne Weil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vanessa Tirneci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexander Kasper
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Adele Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Edelgard Lindhoff-Last
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Eva Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Birgit Linnemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Birgit Linnemann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isert, M., Miesbach, W., Schüttfort, G. et al. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome. Ann Hematol 94, 1291–1299 (2015). https://doi.org/10.1007/s00277-015-2374-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2374-3

Keywords

Search

Navigation